The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
Status:
Completed
Trial end date:
2017-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of volanesorsen given for 52
weeks in participants with Familial Chylomicronemia Syndrome